http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6423314-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
filingDate 2000-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c96d2c5bffe3b7db09a203798e102f0
publicationDate 2002-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6423314-B2
titleOfInvention Tumor derived carbohydrate binding protein
abstract The active, galactose binding site of proteins associated with metastatic tumor cells has been identified and sequenced. The polypeptide comprising the active site may be used as an immunotherapeutic agent. Identification of the site makes possible an in vivo diagnostic assay for metastatic cell as well as therapeutic methodologies and materials.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008089959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004223971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6680306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004043962-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7893252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9649327-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1451227-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9974802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10398778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6890906-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2926818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003109464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9763974-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1451227-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8828971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9339515-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413303-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871925-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007167405-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10420793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10799525-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004121981-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9872909-B2
priorityDate 1995-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227099911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226460103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6993090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127916807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127909126

Total number of triples: 52.